nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—FGB—Parkinson's disease	0.779	1	CbGaD
Sucralfate—EGF—adrenal medulla—Parkinson's disease	0.0182	0.221	CbGeAlD
Sucralfate—EGF—telencephalic ventricle—Parkinson's disease	0.00727	0.0884	CbGeAlD
Sucralfate—FGA—hindbrain—Parkinson's disease	0.0047	0.0571	CbGeAlD
Sucralfate—FGB—embryo—Parkinson's disease	0.00344	0.0418	CbGeAlD
Sucralfate—EGF—hindbrain—Parkinson's disease	0.00343	0.0417	CbGeAlD
Sucralfate—FGA—embryo—Parkinson's disease	0.00294	0.0357	CbGeAlD
Sucralfate—FGA—brainstem—Parkinson's disease	0.00269	0.0327	CbGeAlD
Sucralfate—FGB—cardiovascular system—Parkinson's disease	0.00257	0.0312	CbGeAlD
Sucralfate—PGA5—head—Parkinson's disease	0.00256	0.0311	CbGeAlD
Sucralfate—PGA5—nervous system—Parkinson's disease	0.00243	0.0295	CbGeAlD
Sucralfate—PGA5—central nervous system—Parkinson's disease	0.00234	0.0284	CbGeAlD
Sucralfate—FGA—cardiovascular system—Parkinson's disease	0.0022	0.0267	CbGeAlD
Sucralfate—EGF—embryo—Parkinson's disease	0.00215	0.0261	CbGeAlD
Sucralfate—EGF—brainstem—Parkinson's disease	0.00197	0.0239	CbGeAlD
Sucralfate—EGF—forebrain—Parkinson's disease	0.0019	0.0231	CbGeAlD
Sucralfate—PGA5—brain—Parkinson's disease	0.00186	0.0225	CbGeAlD
Sucralfate—EGF—cardiovascular system—Parkinson's disease	0.00161	0.0195	CbGeAlD
Sucralfate—FGA—head—Parkinson's disease	0.00149	0.0181	CbGeAlD
Sucralfate—FGA—nervous system—Parkinson's disease	0.00141	0.0172	CbGeAlD
Sucralfate—FGA—central nervous system—Parkinson's disease	0.00136	0.0165	CbGeAlD
Sucralfate—FGA—cerebellum—Parkinson's disease	0.00133	0.0161	CbGeAlD
Sucralfate—EGF—spinal cord—Parkinson's disease	0.00122	0.0149	CbGeAlD
Sucralfate—FGF2—medulla oblongata—Parkinson's disease	0.00121	0.0147	CbGeAlD
Sucralfate—FGF2—midbrain—Parkinson's disease	0.00111	0.0134	CbGeAlD
Sucralfate—EGF—head—Parkinson's disease	0.00109	0.0132	CbGeAlD
Sucralfate—FGF2—spinal cord—Parkinson's disease	0.00108	0.0131	CbGeAlD
Sucralfate—FGA—brain—Parkinson's disease	0.00108	0.0131	CbGeAlD
Sucralfate—EGF—nervous system—Parkinson's disease	0.00103	0.0125	CbGeAlD
Sucralfate—EGF—central nervous system—Parkinson's disease	0.000993	0.0121	CbGeAlD
Sucralfate—EGF—cerebellum—Parkinson's disease	0.00097	0.0118	CbGeAlD
Sucralfate—FGF2—cerebellum—Parkinson's disease	0.000856	0.0104	CbGeAlD
Sucralfate—EGF—brain—Parkinson's disease	0.000788	0.00958	CbGeAlD
Sucralfate—FGF2—brain—Parkinson's disease	0.000695	0.00845	CbGeAlD
Sucralfate—ALB—brain—Parkinson's disease	0.000272	0.00331	CbGeAlD
Sucralfate—FGG—Signaling Pathways—DRD1—Parkinson's disease	4.44e-05	0.00032	CbGpPWpGaD
Sucralfate—FGF2—IRS-related events triggered by IGF1R—IL6—Parkinson's disease	4.43e-05	0.000318	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—DRD3—Parkinson's disease	4.39e-05	0.000316	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	4.37e-05	0.000314	CbGpPWpGaD
Sucralfate—FGF2—Disease—RPL6—Parkinson's disease	4.36e-05	0.000314	CbGpPWpGaD
Sucralfate—FGF2—Disease—SNCA—Parkinson's disease	4.36e-05	0.000314	CbGpPWpGaD
Sucralfate—EGF—Downstream signal transduction—IL6—Parkinson's disease	4.35e-05	0.000313	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—IL6—Parkinson's disease	4.33e-05	0.000312	CbGpPWpGaD
Sucralfate—FGF2—Insulin receptor signalling cascade—IL6—Parkinson's disease	4.31e-05	0.00031	CbGpPWpGaD
Sucralfate—FGF2—IGF1R signaling cascade—IL6—Parkinson's disease	4.31e-05	0.00031	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—IL6—Parkinson's disease	4.31e-05	0.00031	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—MAPK8—Parkinson's disease	4.31e-05	0.00031	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—DRD3—Parkinson's disease	4.3e-05	0.00031	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—DRD3—Parkinson's disease	4.3e-05	0.00031	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—IL1B—Parkinson's disease	4.3e-05	0.00031	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—IL6—Parkinson's disease	4.29e-05	0.000309	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—ADRBK1—Parkinson's disease	4.22e-05	0.000303	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PDYN—Parkinson's disease	4.19e-05	0.000301	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	4.19e-05	0.000301	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	4.19e-05	0.000301	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PPP1R1B—Parkinson's disease	4.11e-05	0.000296	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ADRBK1—Parkinson's disease	4.1e-05	0.000295	CbGpPWpGaD
Sucralfate—FGF2—Immune System—DCTN1—Parkinson's disease	4.1e-05	0.000295	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	4.09e-05	0.000295	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	4.04e-05	0.00029	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—IL6—Parkinson's disease	4.04e-05	0.00029	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—IL6—Parkinson's disease	4.04e-05	0.00029	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	4.02e-05	0.000289	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ADRBK1—Parkinson's disease	4.02e-05	0.000289	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ADRBK1—Parkinson's disease	4.02e-05	0.000289	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—MAPK8—Parkinson's disease	4e-05	0.000288	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—IL6—Parkinson's disease	4e-05	0.000288	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HTR7—Parkinson's disease	3.97e-05	0.000286	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—DRD2—Parkinson's disease	3.97e-05	0.000286	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—IL6—Parkinson's disease	3.96e-05	0.000285	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—IL6—Parkinson's disease	3.95e-05	0.000284	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GFAP—Parkinson's disease	3.94e-05	0.000283	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GRM5—Parkinson's disease	3.89e-05	0.00028	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—DRD2—Parkinson's disease	3.89e-05	0.00028	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—DRD2—Parkinson's disease	3.89e-05	0.00028	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HTR7—Parkinson's disease	3.89e-05	0.00028	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HTR7—Parkinson's disease	3.89e-05	0.00028	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—ABL1—Parkinson's disease	3.89e-05	0.00028	CbGpPWpGaD
Sucralfate—FGA—Disease—MTHFR—Parkinson's disease	3.89e-05	0.00028	CbGpPWpGaD
Sucralfate—EGF—Immune System—ADRBK1—Parkinson's disease	3.88e-05	0.000279	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	3.81e-05	0.000274	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.76e-05	0.000271	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	3.74e-05	0.000269	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-DRA—Parkinson's disease	3.73e-05	0.000268	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	3.73e-05	0.000268	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PLA2G6—Parkinson's disease	3.69e-05	0.000265	CbGpPWpGaD
Sucralfate—FGA—Disease—APOE—Parkinson's disease	3.62e-05	0.00026	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RIT2—Parkinson's disease	3.59e-05	0.000259	CbGpPWpGaD
Sucralfate—EGF—Disease—ADRBK1—Parkinson's disease	3.58e-05	0.000258	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—IL6—Parkinson's disease	3.58e-05	0.000258	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	3.57e-05	0.000257	CbGpPWpGaD
Sucralfate—EGF—Disease—HSPA1A—Parkinson's disease	3.56e-05	0.000256	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL1B—Parkinson's disease	3.5e-05	0.000252	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—ABL1—Parkinson's disease	3.44e-05	0.000247	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGF20—Parkinson's disease	3.41e-05	0.000246	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GRK5—Parkinson's disease	3.41e-05	0.000245	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PARK2—Parkinson's disease	3.37e-05	0.000242	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGF20—Parkinson's disease	3.34e-05	0.00024	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IGF2—Parkinson's disease	3.33e-05	0.00024	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ADORA2A—Parkinson's disease	3.31e-05	0.000238	CbGpPWpGaD
Sucralfate—FGF2—Disease—RPL14—Parkinson's disease	3.31e-05	0.000238	CbGpPWpGaD
Sucralfate—FGF2—Disease—RPL23A—Parkinson's disease	3.31e-05	0.000238	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IGF2—Parkinson's disease	3.26e-05	0.000235	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IGF2—Parkinson's disease	3.26e-05	0.000235	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IGF1R—Parkinson's disease	3.22e-05	0.000232	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EDN1—Parkinson's disease	3.18e-05	0.000229	CbGpPWpGaD
Sucralfate—EGF—Immune System—ABL1—Parkinson's disease	3.16e-05	0.000228	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—CASP3—Parkinson's disease	3.16e-05	0.000227	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IGF1R—Parkinson's disease	3.15e-05	0.000227	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IGF1R—Parkinson's disease	3.15e-05	0.000227	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	3.12e-05	0.000225	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EDN1—Parkinson's disease	3.12e-05	0.000224	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EDN1—Parkinson's disease	3.12e-05	0.000224	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MAG—Parkinson's disease	3.12e-05	0.000224	CbGpPWpGaD
Sucralfate—FGA—Disease—INS—Parkinson's disease	3.09e-05	0.000222	CbGpPWpGaD
Sucralfate—FGF2—Disease—RPS8—Parkinson's disease	3.08e-05	0.000222	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGF20—Parkinson's disease	3.08e-05	0.000222	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—IL6—Parkinson's disease	3.06e-05	0.00022	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GRM4—Parkinson's disease	3.06e-05	0.00022	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—INSR—Parkinson's disease	3.05e-05	0.00022	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.98e-05	0.000214	CbGpPWpGaD
Sucralfate—EGF—Immune System—HGF—Parkinson's disease	2.97e-05	0.000214	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—CASP3—Parkinson's disease	2.96e-05	0.000213	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—IL6—Parkinson's disease	2.93e-05	0.000211	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NGF—Parkinson's disease	2.92e-05	0.00021	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PENK—Parkinson's disease	2.9e-05	0.000208	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAG—Parkinson's disease	2.9e-05	0.000208	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGB—Parkinson's disease	2.89e-05	0.000208	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—IL6—Parkinson's disease	2.89e-05	0.000208	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HTR1A—Parkinson's disease	2.87e-05	0.000207	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	2.87e-05	0.000206	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NGF—Parkinson's disease	2.86e-05	0.000206	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NGF—Parkinson's disease	2.86e-05	0.000206	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	2.83e-05	0.000204	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TAC1—Parkinson's disease	2.83e-05	0.000203	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HTR2A—Parkinson's disease	2.78e-05	0.0002	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	2.78e-05	0.0002	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—DRD1—Parkinson's disease	2.77e-05	0.0002	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—IL6—Parkinson's disease	2.76e-05	0.000198	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—IL6—Parkinson's disease	2.75e-05	0.000198	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—IL6—Parkinson's disease	2.74e-05	0.000197	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—IL6—Parkinson's disease	2.73e-05	0.000196	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HTR2A—Parkinson's disease	2.73e-05	0.000196	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HTR2A—Parkinson's disease	2.73e-05	0.000196	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—MAPK8—Parkinson's disease	2.72e-05	0.000196	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—IL6—Parkinson's disease	2.71e-05	0.000195	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	2.69e-05	0.000193	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—DRD3—Parkinson's disease	2.69e-05	0.000193	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PDYN—Parkinson's disease	2.65e-05	0.000191	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—APOE—Parkinson's disease	2.59e-05	0.000186	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—INS—Parkinson's disease	2.57e-05	0.000185	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—IL6—Parkinson's disease	2.55e-05	0.000184	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—IL6—Parkinson's disease	2.55e-05	0.000184	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	2.55e-05	0.000184	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—Parkinson's disease	2.54e-05	0.000183	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	2.54e-05	0.000183	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—APOE—Parkinson's disease	2.53e-05	0.000182	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—APOE—Parkinson's disease	2.53e-05	0.000182	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—IL6—Parkinson's disease	2.53e-05	0.000182	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	2.52e-05	0.000181	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—IL6—Parkinson's disease	2.51e-05	0.00018	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ADRBK1—Parkinson's disease	2.51e-05	0.00018	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—IL6—Parkinson's disease	2.5e-05	0.00018	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GFAP—Parkinson's disease	2.49e-05	0.000179	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GRM5—Parkinson's disease	2.46e-05	0.000177	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—MAPK8—Parkinson's disease	2.46e-05	0.000177	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ADRBK1—Parkinson's disease	2.46e-05	0.000177	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HTR7—Parkinson's disease	2.43e-05	0.000175	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—DRD2—Parkinson's disease	2.43e-05	0.000175	CbGpPWpGaD
Sucralfate—EGF—Disease—MTHFR—Parkinson's disease	2.43e-05	0.000175	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.34e-05	0.000168	CbGpPWpGaD
Sucralfate—FGF2—Disease—ADRBK1—Parkinson's disease	2.27e-05	0.000163	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	2.26e-05	0.000163	CbGpPWpGaD
Sucralfate—EGF—Disease—APOE—Parkinson's disease	2.26e-05	0.000163	CbGpPWpGaD
Sucralfate—FGF2—Disease—HSPA1A—Parkinson's disease	2.25e-05	0.000162	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	2.22e-05	0.00016	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—INS—Parkinson's disease	2.21e-05	0.000159	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ND3—Parkinson's disease	2.2e-05	0.000158	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MCCC1—Parkinson's disease	2.2e-05	0.000158	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—INS—Parkinson's disease	2.17e-05	0.000156	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—INS—Parkinson's disease	2.17e-05	0.000156	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGF20—Parkinson's disease	2.16e-05	0.000155	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ADORA2A—Parkinson's disease	2.09e-05	0.000151	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TALDO1—Parkinson's disease	2.07e-05	0.000149	CbGpPWpGaD
Sucralfate—ALB—Metabolism—OMD—Parkinson's disease	2.07e-05	0.000149	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL6—Parkinson's disease	2.05e-05	0.000148	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	2.04e-05	0.000147	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF2—Parkinson's disease	2.04e-05	0.000146	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	2.02e-05	0.000145	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ABL1—Parkinson's disease	2e-05	0.000144	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF1R—Parkinson's disease	1.97e-05	0.000142	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—FGB—Parkinson's disease	1.97e-05	0.000141	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NDUFB11—Parkinson's disease	1.96e-05	0.000141	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EDN1—Parkinson's disease	1.95e-05	0.00014	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—INSR—Parkinson's disease	1.93e-05	0.000139	CbGpPWpGaD
Sucralfate—EGF—Disease—INS—Parkinson's disease	1.93e-05	0.000139	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HGF—Parkinson's disease	1.88e-05	0.000135	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GCH1—Parkinson's disease	1.87e-05	0.000135	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGB—Parkinson's disease	1.83e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HTR1A—Parkinson's disease	1.82e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TAC1—Parkinson's disease	1.79e-05	0.000129	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NGF—Parkinson's disease	1.79e-05	0.000129	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—DRD1—Parkinson's disease	1.76e-05	0.000126	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—IL6—Parkinson's disease	1.74e-05	0.000125	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HTR2A—Parkinson's disease	1.7e-05	0.000122	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—DRD3—Parkinson's disease	1.7e-05	0.000122	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.69e-05	0.000121	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GBA—Parkinson's disease	1.67e-05	0.00012	CbGpPWpGaD
Sucralfate—ALB—Metabolism—FBP1—Parkinson's disease	1.67e-05	0.00012	CbGpPWpGaD
Sucralfate—ALB—Metabolism—DBH—Parkinson's disease	1.67e-05	0.00012	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CASP3—Parkinson's disease	1.65e-05	0.000118	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	1.63e-05	0.000117	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CASP3—Parkinson's disease	1.61e-05	0.000116	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CASP3—Parkinson's disease	1.61e-05	0.000116	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ADRBK1—Parkinson's disease	1.59e-05	0.000114	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—APOE—Parkinson's disease	1.58e-05	0.000114	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—IL6—Parkinson's disease	1.57e-05	0.000113	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL1B—Parkinson's disease	1.56e-05	0.000112	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MAPK8—Parkinson's disease	1.55e-05	0.000112	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—DRD2—Parkinson's disease	1.54e-05	0.000111	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HTR7—Parkinson's disease	1.54e-05	0.000111	CbGpPWpGaD
Sucralfate—FGF2—Disease—MTHFR—Parkinson's disease	1.54e-05	0.00011	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MAPK8—Parkinson's disease	1.51e-05	0.000109	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MAPK8—Parkinson's disease	1.48e-05	0.000107	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MAPK8—Parkinson's disease	1.48e-05	0.000107	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SOD1—Parkinson's disease	1.46e-05	0.000105	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.46e-05	0.000105	CbGpPWpGaD
Sucralfate—EGF—Immune System—MAPK8—Parkinson's disease	1.43e-05	0.000103	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOE—Parkinson's disease	1.43e-05	0.000103	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.4e-05	0.000101	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—Parkinson's disease	1.39e-05	0.0001	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ABL1—Parkinson's disease	1.39e-05	0.0001	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IGF2—Parkinson's disease	1.39e-05	9.97e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—INS—Parkinson's disease	1.35e-05	9.72e-05	CbGpPWpGaD
Sucralfate—FGA—Disease—IL6—Parkinson's disease	1.35e-05	9.72e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HGF—Parkinson's disease	1.31e-05	9.41e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF2—Parkinson's disease	1.29e-05	9.27e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF1R—Parkinson's disease	1.25e-05	8.96e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EDN1—Parkinson's disease	1.23e-05	8.86e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—DDC—Parkinson's disease	1.22e-05	8.8e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—INS—Parkinson's disease	1.22e-05	8.79e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.22e-05	8.75e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.17e-05	8.4e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTA4—Parkinson's disease	1.16e-05	8.31e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.14e-05	8.21e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NGF—Parkinson's disease	1.13e-05	8.14e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—IL6—Parkinson's disease	1.12e-05	8.08e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HTR2A—Parkinson's disease	1.08e-05	7.75e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLA2G6—Parkinson's disease	1.04e-05	7.49e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MAOB—Parkinson's disease	1.03e-05	7.41e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CASP3—Parkinson's disease	1.01e-05	7.24e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOE—Parkinson's disease	1e-05	7.2e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—IL6—Parkinson's disease	9.92e-06	7.14e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL1B—Parkinson's disease	9.87e-06	7.1e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9.8e-06	7.05e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL6—Parkinson's disease	9.66e-06	6.95e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL6—Parkinson's disease	9.46e-06	6.81e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL6—Parkinson's disease	9.46e-06	6.81e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MAPK8—Parkinson's disease	9.25e-06	6.65e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL6—Parkinson's disease	9.13e-06	6.57e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MAPK8—Parkinson's disease	9.05e-06	6.51e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—INS—Parkinson's disease	8.55e-06	6.15e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—IL6—Parkinson's disease	8.43e-06	6.07e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP2D6—Parkinson's disease	7.65e-06	5.51e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CTGF—Parkinson's disease	7.51e-06	5.41e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP2E1—Parkinson's disease	7e-06	5.04e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NQO1—Parkinson's disease	6.92e-06	4.98e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TH—Parkinson's disease	6.82e-06	4.91e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYCS—Parkinson's disease	6.55e-06	4.71e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CASP3—Parkinson's disease	6.37e-06	4.58e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL6—Parkinson's disease	5.91e-06	4.25e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAPK8—Parkinson's disease	5.85e-06	4.21e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—COMT—Parkinson's disease	5.8e-06	4.17e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL6—Parkinson's disease	5.78e-06	4.16e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTP1—Parkinson's disease	5.77e-06	4.15e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MAOA—Parkinson's disease	5.76e-06	4.14e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HMOX1—Parkinson's disease	5.69e-06	4.1e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ABCB1—Parkinson's disease	5.47e-06	3.93e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6—Parkinson's disease	5.34e-06	3.84e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTM1—Parkinson's disease	5.31e-06	3.82e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GPX1—Parkinson's disease	5.08e-06	3.66e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MTHFR—Parkinson's disease	4.69e-06	3.37e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOE—Parkinson's disease	4.37e-06	3.14e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6—Parkinson's disease	3.74e-06	2.69e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—INS—Parkinson's disease	3.73e-06	2.68e-05	CbGpPWpGaD
